TY - JOUR T1 - Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study JF - Lancet Gastroenterol Hepatol Y1 - 2019 A1 - Bethea, ED A1 - Gaj, K A1 - Gustafson, JL A1 - et, al VL - 4 SP - 771-780 ER -